Explainer
Cannabis and health: what the evidence shows
The best-known evidence review, by the US National Academies in 2017, found conclusive evidence that certain oral cannabinoids help with chemotherapy nausea, substantial evidence for multiple sclerosis spasms, and evidence of pain relief in adults with chronic pain.[1][2] It also found cannabis likely raises the risk of schizophrenia and other psychoses, and that use before driving raises crash risk.[3][4] NIDA says studies estimate 22% to 30% of people who use cannabis have cannabis use disorder.[5]
This page is general information, not medical advice. Talk to a doctor or other clinician before using cannabis for a health condition, especially if you are pregnant, take other medicines or have a history of mental illness.
For help with cannabis or other substance use, the US SAMHSA National Helpline is free and confidential: 1-800-662-HELP (4357), or visit FindTreatment.gov.[6] If you or someone else is in crisis, call or text 988.[7]
The health effects of cannabis are still being worked out. A widely cited summary is a 2017 National Academies report, which weighed more than 10,000 scientific abstracts to reach nearly 100 conclusions.[8] NIDA, the federal research institute on drug use, publishes its own evidence summary.[5] This page sets out what each says, and how strong the evidence is.
What cannabis contains
The cannabis plant contains at least 125 cannabinoids. The best known are delta-9 THC, which is intoxicating, and cannabidiol (CBD), which is not.[9] Products have become much stronger: NIDA says the THC potency of illegal cannabis seized by police quadrupled from 3.96% in 1995 to 16.14% in 2022, and dispensary flower and concentrates can exceed 40% THC.[10]
CBD is not intoxicating but can cause side effects such as drowsiness, decreased appetite, vomiting and diarrhea, and products have been found to contain different amounts of CBD than labeled.[11] Delta-8 THC products are not FDA-approved, and eating large amounts has led to medical emergencies.[12]
Medical uses with good evidence
The National Academies graded evidence by strength. Its two strongest findings concerned certain oral cannabinoid medicines:
- Chemotherapy nausea and vomiting: conclusive evidence that certain oral cannabinoids prevent and treat it in adults.[2]
- Multiple sclerosis spasms: substantial evidence that short-term use of certain oral cannabinoids improved reported symptoms.[2]
- Chronic pain: evidence that adults treated with cannabis or cannabinoids were more likely to have a significant reduction in pain.[1]
FDA has not approved a marketing application for cannabis to treat any condition. It has approved one cannabis-derived drug, Epidiolex (purified CBD for seizures in Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex), and cannabis-related drugs containing synthetic THC (dronabinol, sold as Marinol and Syndros) or a THC-like compound (nabilone, sold as Cesamet).[13]
Risks: mental health, driving and the body
Mental health. The National Academies concluded that cannabis use is likely to increase the risk of developing schizophrenia, other psychoses and social anxiety disorders, and to a lesser extent depression.[3] NIDA adds that intoxication can trigger a temporary psychotic episode in some people, especially at high doses.[14] NIDA says longer-term studies are still needed to show whether, how much and for whom cannabis causes poor mental health outcomes.[14]
Driving and children. The National Academies found that cannabis use before driving increases the risk of a crash, and that children in states where cannabis is legal face a higher risk of unintentional cannabis overdose injuries.[4] NIDA describes children eating edibles such as gummies, usually by accident, as a growing concern that can lead to hospitalization.[15]
Lungs and cancer. Cannabis smoke contains many of the same toxins, irritants and carcinogens as tobacco smoke.[16] Regular cannabis smoking is linked to more chronic bronchitis and worse cough and phlegm, which quitting is likely to reduce.[17] However, the 2017 review found evidence suggesting smoking cannabis does not increase the risk of cancers often associated with tobacco, such as lung and head and neck cancers.[18]
Heart and gut. Cannabis can raise heart rate and blood pressure right after use; whether long-term use directly causes heart disease is not yet established.[19] Long-term heavy use can cause cannabinoid hyperemesis syndrome, with nausea, vomiting and abdominal pain, which resolves only when the person stops using cannabis completely.[20]
Pregnancy. NIDA says research has linked cannabis use in pregnancy with lower birth weight, preterm birth and other negative outcomes.[21] The National Academies found some evidence for the birth weight link but called other outcomes unclear.[22]
Cannabis use disorder
NIDA says studies estimate that 22% to 30% of people who use cannabis have cannabis use disorder, and that how often someone uses is the strongest predictor.[5] The National Academies similarly found that more frequent use, and starting younger, make problem use more likely.[23] Behavioral treatments such as cognitive behavioral therapy, motivational enhancement therapy and contingency management can be effective; there are no FDA-approved medications for the disorder.[24]
The National Academies findings above come from its original report; check NIDA for newer research summaries. For how cannabis is classified under federal law, see cannabis rescheduling explained.
Read next
Next in the crash course
Cannabis rescheduling explained: the DEA process and where it stands
How marijuana rescheduling works, what the 2026 rule moved to Schedule III, what it did not change, and where the broader DEA proceeding stands.
Questions readers ask
Does cannabis help with pain?
The 2017 National Academies review found evidence that adults with chronic pain treated with cannabis or cannabinoids were more likely to have a significant reduction in pain. It found conclusive evidence that certain oral cannabinoids prevent and treat chemotherapy-induced nausea and vomiting.[1][2]
Can cannabis cause psychosis?
The National Academies concluded cannabis use is likely to increase the risk of schizophrenia and other psychoses. NIDA says intoxication can trigger a temporary psychotic episode in some people, especially at high doses, but that longer-term studies are still needed to show whether and for whom cannabis causes poor mental health outcomes.[3][14]
Is cannabis addictive?
NIDA says studies estimate 22% to 30% of people who use cannabis have cannabis use disorder, and frequency of use is the strongest predictor. Behavioral therapies can help; no medication is FDA-approved for it.[5][24]
Does smoking cannabis cause lung cancer?
The 2017 review found evidence suggesting smoking cannabis does not raise the risk of cancers often linked to tobacco, such as lung cancer. It did link regular cannabis smoking to more chronic bronchitis and worse respiratory symptoms, and NIDA notes cannabis smoke contains many of the same toxins as tobacco smoke.[18][17][16]
Which cannabis-based medicines has FDA approved?
FDA has not approved a marketing application for cannabis to treat any condition. It has approved Epidiolex, a purified CBD drug for certain seizure disorders, and drugs containing dronabinol (Marinol, Syndros) or nabilone (Cesamet).[13]
Sources
· 24 claims from 3 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
The 2017 National Academies committee found evidence that adults with chronic pain treated with cannabis or cannabinoids were more likely to have a significant reduction in pain symptoms. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Therapeutic Effects (retrieved 2026-11-07)
- [2]
The committee found substantial evidence that short-term use of certain oral cannabinoids improved reported multiple sclerosis-related muscle spasms, and conclusive evidence that certain oral cannabinoids prevent and treat chemotherapy-induced nausea and vomiting in adults. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Therapeutic Effects (retrieved 2026-11-07)
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Therapeutic Effects (retrieved 2026-11-07)
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Therapeutic Effects (retrieved 2026-11-07)
- [3]
The committee concluded that cannabis use is likely to increase the risk of developing schizophrenia, other psychoses and social anxiety disorders, and to a lesser extent depression. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Mental Health (retrieved 2026-11-07)
- [4]
The committee found evidence that cannabis use before driving increases the risk of a motor vehicle crash, and that in states where cannabis is legal children face a higher risk of unintentional cannabis overdose injuries. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Injury and Death (retrieved 2026-11-07)
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Injury and Death (retrieved 2026-11-07)
- [5]
NIDA says studies estimate 22% to 30% of people who use cannabis have cannabis use disorder, and that how often someone uses is the strongest predictor. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Is cannabis addictive? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Is cannabis addictive? (retrieved 2026-11-07)
- [6]
The SAMHSA National Helpline, 1-800-662-HELP (4357), and FindTreatment.gov give US referrals to substance use and mental health treatment programs. confirmedas of 2026-11-07
- Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
- [7]
People in the US experiencing a substance use or mental health crisis can call or text 988, or chat at 988lifeline.org, to reach the 988 Suicide & Crisis Lifeline. confirmedas of 2026-11-07
- Research Topics · National Institute on Drug Abuse · Primary source · In an emergency? Need treatment? (retrieved 2026-11-07)
- [8]
A January 2017 National Academies report reviewed more than 10,000 scientific abstracts and reached nearly 100 conclusions on the health effects of cannabis and cannabinoids. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · News release, 12 January 2017 (retrieved 2026-11-07)
- [9]
NIDA says the cannabis plant contains at least 125 cannabinoids, including intoxicating delta-9 THC and non-intoxicating cannabidiol (CBD). confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is cannabis? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is cannabis? (retrieved 2026-11-07)
- [10]
NIDA says the THC potency of illegal cannabis seized by law enforcement quadrupled from 3.96% in 1995 to 16.14% in 2022, and dispensary flower and concentrates can exceed 40% THC. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Are cannabis products getting stronger? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Are cannabis products getting stronger? (retrieved 2026-11-07)
- [11]
NIDA says CBD is not intoxicating but may cause side effects such as drowsiness, decreased appetite, vomiting and diarrhea, and that products have been found to contain different amounts of CBD than labeled. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is CBD? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is CBD? (retrieved 2026-11-07)
- [12]
NIDA says delta-8 THC products have not been FDA-approved for safe use and that eating large amounts has led to medical emergencies. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is Delta-8 THC? (retrieved 2026-11-07)
- [13]
FDA has not approved a marketing application for cannabis for any condition but has approved one cannabis-derived drug (Epidiolex, purified CBD for seizures in Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex) and cannabis-related drugs containing dronabinol, a synthetic THC (Marinol, Syndros), or nabilone, a synthetic compound similar to THC (Cesamet). confirmedas of 2026-11-07
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q3 (retrieved 2026-11-07)
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q3 (retrieved 2026-11-07)
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q3 (retrieved 2026-11-07)
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q2 (retrieved 2026-11-07)
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q2 (retrieved 2026-11-07)
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) · U.S. Food and Drug Administration · Primary source · Q2 (retrieved 2026-11-07)
- [14]
NIDA says cannabis intoxication can induce a temporary psychotic episode in some people, especially at high doses, and that longitudinal research is still needed to establish whether and for whom cannabis causes poor mental health outcomes. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is the relationship between cannabis use and mental health? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is the relationship between cannabis use and mental health? (retrieved 2026-11-07)
- [15]
NIDA says children eating cannabis edibles such as gummies, usually by accident, is a growing health concern that can lead to hospitalization. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What are the short-term health effects of cannabis use? (retrieved 2026-11-07)
- [16]
NIDA says cannabis smoke contains many of the same toxins, irritants and carcinogens as tobacco smoke. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Harms to Lung Health (retrieved 2026-11-07)
- [17]
The committee found that regular cannabis smoking is linked to more frequent chronic bronchitis episodes and worse respiratory symptoms, which quitting is likely to reduce. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Respiratory Disease (retrieved 2026-11-07)
- [18]
The 2017 committee found evidence suggesting that smoking cannabis does not increase the risk of cancers often associated with tobacco, such as lung and head and neck cancers. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Cancer (retrieved 2026-11-07)
- [19]
NIDA says cannabis can raise heart rate and blood pressure right after use, and that more research is needed to know whether long-term use directly causes cardiovascular disease. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Cardiovascular Effects (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Cardiovascular Effects (retrieved 2026-11-07)
- [20]
NIDA describes cannabinoid hyperemesis syndrome as nausea, vomiting and abdominal pain after long-term heavy cannabis use, which resolves only when the person stops using cannabis completely. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is cannabinoid hyperemesis syndrome? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · What is cannabinoid hyperemesis syndrome? (retrieved 2026-11-07)
- [21]
NIDA says research has linked cannabis use in pregnancy with lower birth weight, preterm birth and other negative outcomes. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Does cannabis use during pregnancy affect a developing baby? (retrieved 2026-11-07)
- [22]
The committee found some evidence that smoking cannabis during pregnancy is linked to lower birth weight, with the relationship to other pregnancy and childhood outcomes unclear. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Prenatal, Perinatal, and Neonatal Exposure (retrieved 2026-11-07)
- [23]
The committee found that more frequent cannabis use, and starting at a younger age, increase the likelihood of developing problem cannabis use. confirmedas of 2026-11-07
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Problem Cannabis Use (retrieved 2026-11-07)
- Health Effects of Marijuana and Cannabis-Derived Products Presented in New Report · National Academies of Sciences, Engineering, and Medicine · Primary source · 2017-01-12 · Problem Cannabis Use (retrieved 2026-11-07)
- [24]
NIDA says behavioral treatments such as cognitive behavioral therapy, motivational enhancement therapy and contingency management can be effective for cannabis use disorder, and there are no FDA-approved medications for it. confirmedas of 2026-11-07
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Are there treatments for cannabis use disorder? (retrieved 2026-11-07)
- Cannabis (Marijuana) · National Institute on Drug Abuse · Primary source · Are there treatments for cannabis use disorder? (retrieved 2026-11-07)
Revision history (1)
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.
Cite this page
"Cannabis and health: what the evidence shows." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/cannabis-health-evidence-explained
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.